Galectin Therapeutics Inc (NASDAQ:GALT) has a beta value of 100.00% and has seen 468.62 shares traded in the last trading session. The company, currently valued at $153.17M, closed the last trade at $3.29 per share which meant it lost -$2.71 on the day or 2.42% during that session. The GALT stock price is -0.3% off its 52-week high price of $3.30 and 77.81% above the 52-week low of $0.73. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.29 million shares traded. The 3-month trading volume is 9.22 shares.
Galectin Therapeutics Inc (NASDAQ:GALT) trade information
Sporting 2.42% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the GALT stock price touched $3.29 or saw a rise of 15.64%. Year-to-date, Galectin Therapeutics Inc shares have moved -3.20%, while the 5-day performance has seen it change 80.60%. Over the past 30 days, the shares of Galectin Therapeutics Inc (NASDAQ:GALT) have changed 87.60%. Short interest in the company has seen 8.9 million shares shorted with days to cover at 52.08.
Galectin Therapeutics Inc (GALT) estimates and forecasts
The company’s shares have gained 4.76% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -13.03% -23.89% over the past 5 years. Earnings growth for 2025 is a modest 11.84% while over the next 5 years, the company’s earnings are expected to increase by 5.57%.
GALT Dividends
Galectin Therapeutics Inc is expected to release its next earnings report on 2025-May-15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Galectin Therapeutics Inc (NASDAQ:GALT)’s Major holders
Insiders own 30.44% of the company shares, while shares held by institutions stand at 15.78% with a share float percentage of 22.68%. Investors are also buoyed by the number of investors in a company, with Galectin Therapeutics Inc having a total of 120.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 2.12 million shares worth more than $4.78 million. As of 2024-06-30, VANGUARD GROUP INC held 3.4002% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 1.56 million shares as of 2024-06-30. The firm’s total holdings are worth over $3.53 million and represent 2.5128% of shares outstanding.
